{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:30:59Z","timestamp":1791228659767,"version":"4.1.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10,1]]},"DOI":"10.1309\/ajcptus5exas6dkz","type":"journal-article","created":{"date-parts":[[2011,9,13]],"date-time":"2011-09-13T18:12:31Z","timestamp":1315937551000},"page":"578-586","source":"Crossref","is-referenced-by-count":198,"title":["Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV+ Cytology-Negative Results"],"prefix":"10.1093","volume":"136","author":[{"suffix":"Jr","given":"Thomas C.","family":"Wright","sequence":"first","affiliation":[{"name":"Department of Pathology, Columbia University School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Stoler","sequence":"additional","affiliation":[{"name":"University of Virginia Health System, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abha","family":"Sharma","sequence":"additional","affiliation":[{"name":"Roche Molecular Systems, Pleasanton, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guili","family":"Zhang","sequence":"additional","affiliation":[{"name":"Roche Molecular Systems, Pleasanton, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Behrens","sequence":"additional","affiliation":[{"name":"Roche Molecular Systems, Pleasanton, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa L.","family":"Wright","sequence":"additional","affiliation":[{"name":"Roche Molecular Systems, Pleasanton, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,10,1]]},"reference":[{"key":"key\n\t\t\t\t20180602024047_b1-1360578","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"key\n\t\t\t\t20180602024047_b2-1360578","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180602024047_b3-1360578","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ajog.2007.07.047","article-title":"2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20180602024047_b4-1360578","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archinternmed.2010.134","article-title":"Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?","volume":"170","author":"Saraiya","year":"2010","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20180602024047_b5-1360578","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/cncr.22875","article-title":"Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP)","volume":"110","author":"Saraiya","year":"2007","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180602024047_b6-1360578","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","article-title":"Chapter 1: Human papillomavirus and cervical cancer: burden and assessment of causality","author":"Bosch","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"key\n\t\t\t\t20180602024047_b7-1360578","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"de Sanjose","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180602024047_b8-1360578","unstructured":"American Society for Colposcopy and Cervical Pathology HPV Genotyping Clinical Update 2009. http:\/\/www.asccp.org\/consensus.shtml. Accessed February 2011."},{"key":"key\n\t\t\t\t20180602024047_b9-1360578","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study","volume":"135","author":"Stoler","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602024047_b10-1360578","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4419-0489-8","volume-title":"Blaustein\u2019s Pathology of the Female Genital Tract","author":"Kurman","year":"2011"},{"key":"key\n\t\t\t\t20180602024047_b11-1360578","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180602024047_b12-1360578","first-page":"112","volume-title":"Bootstrapping Methods: A Practitioner\u2019s Guide","author":"Chernick","year":"1999"},{"key":"key\n\t\t\t\t20180602024047_b13-1360578","article-title":"cobas HPV Test [package insert]","year":"2009"},{"key":"key\n\t\t\t\t20180602024047_b14-1360578","article-title":"The AMPLICOR Human Papillomavirus (HPV) test [package insert]","year":"2008"},{"key":"key\n\t\t\t\t20180602024047_b15-1360578","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bjc.6602728","article-title":"The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women","volume":"93","author":"Bigras","year":"2005","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20180602024047_b16-1360578","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20180602024047_b17-1360578","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jnci\/djj209","article-title":"Human papillomavirus testing and liquid-based cytology: results at recruitment from the New Technologies for Cervical Cancer randomized controlled trial","volume":"98","author":"Ronco","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180602024047_b18-1360578","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180602024047_b19-1360578","article-title":"A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial [published online ahead of print February 18, 2011]","author":"Kitchener","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t20180602024047_b20-1360578","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"Kjaer","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 3","key":"key\n\t\t\t\t20180602024047_b21-1360578","first-page":"S3\/42","article-title":"Chapter 5: Updating the natural history of HPV and anogenital cancer","volume":"24","author":"Moscicki","year":"2006","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180602024047_b22-1360578","article-title":"The ATHENA human papillomavirus study: design, methods, and baseline results","author":"Wright","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20180602024047_b23-1360578","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180602024047_b24-1360578","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00006250-200008000-00012","article-title":"Frequency of cervical smear abnormalities within 3 years of normal cytology","volume":"96","author":"Sawaya","year":"2000","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20180602024047_b25-1360578","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.288.14.1749","article-title":"Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral","volume":"288","author":"Kulasingam","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180602024047_b26-1360578","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180602024047_b27-1360578","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/sim.907","article-title":"Estimating prevalence when the true disease status is incompletely ascertained","volume":"20","author":"Sasieni","year":"2001","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20180602024047_b28-1360578","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.AOG.0000109426.82624.f8","article-title":"Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening","volume":"103","author":"Wright","year":"2004","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20180602024047_b29-1360578","doi-asserted-by":"crossref","first-page":"356.e1","DOI":"10.1016\/j.ajog.2007.07.049","article-title":"Risk assessment to guide the prevention of cervical cancer","volume":"197","author":"Castle","year":"2007","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/136\/4\/578\/24991737\/ajcpath136-0578.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T09:15:02Z","timestamp":1560590102000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/136\/4\/578\/1760839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,1]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,10,1]]},"published-print":{"date-parts":[[2011,10,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcptus5exas6dkz","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,10,1]]},"published":{"date-parts":[[2011,10,1]]}}}